Clinical Trials Directory

Trials / Sponsors / Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

Industry · 17 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingStudy to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 22025-12-29
CompletedA Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg R
Renal Impairment
Phase 12024-03-06
Active Not RecruitingA Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NA
NASH, Cirrhosis, Liver
Phase 32022-08-26
Active Not RecruitingA Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatt
Non-Alcoholic Fatty Liver Disease
Phase 32021-07-09
CompletedA Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Diseas
Non-Alcoholic Fatty Liver Disease
Phase 32019-12-16
CompletedDrug Interaction Study of MGL-3196 With Clopidogrel
Healthy
Phase 12019-07-26
Active Not RecruitingA Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosi
NASH - Nonalcoholic Steatohepatitis
Phase 32019-03-28
CompletedDrug Interaction Study of MGL-3196 With Pioglitazone
Healthy
Phase 12018-11-09
CompletedPhase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in
Hepatic Impairment, NASH - Nonalcoholic Steatohepatitis, Cirrhosis, Liver
Phase 12018-10-25
CompletedBioavailability Study of MGL-3196 Tablets Compared to Capsules
Healthy
Phase 12018-02-05
CompletedRadiolabeled Study to Determine the Mass Balance of [14C] MGL-3196
Healthy
Phase 12017-08-06
CompletedStudy of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Heterozygous Familial Hypercholesterolemia
Phase 22017-02-23
CompletedPhase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Non-alcoholic Steatohepatitis
Phase 22016-10-18
CompletedDrug Interaction Study of MGL-3196 With Atorvastatin
Healthy
Phase 12016-04-01
CompletedDrug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin
Healthy
Phase 12015-09-01
CompletedAscending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects
Drug Safety
Phase 12012-01-01
CompletedAscending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects
Drug Safety
Phase 12011-06-01